Anti-NAPG monoclonal antibody
Pre-made anti-NAPG monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to NAPG/NAPG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2623-Ab-1/ GM-Tg-hg-IP2623-Ab-2 | Anti-Human NAPG monoclonal antibody | Human |
GM-Tg-rg-IP2623-Ab-1/ GM-Tg-rg-IP2623-Ab-2 | Anti-Rat NAPG monoclonal antibody | Rat |
GM-Tg-mg-IP2623-Ab-1/ GM-Tg-mg-IP2623-Ab-2 | Anti-Mouse NAPG monoclonal antibody | Mouse |
GM-Tg-cynog-IP2623-Ab-1/ GM-Tg-cynog-IP2623-Ab-2 | Anti-Cynomolgus/ Rhesus macaque NAPG monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2623-Ab-1/ GM-Tg-felg-IP2623-Ab-2 | Anti-Feline NAPG monoclonal antibody | Feline |
GM-Tg-cang-IP2623-Ab-1/ GM-Tg-cang-IP2623-Ab-2 | Anti-Canine NAPG monoclonal antibody | Canine |
GM-Tg-bovg-IP2623-Ab-1/ GM-Tg-bovg-IP2623-Ab-2 | Anti-Bovine NAPG monoclonal antibody | Bovine |
GM-Tg-equg-IP2623-Ab-1/ GM-Tg-equg-IP2623-Ab-2 | Anti-Equine NAPG monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2623-Ab-1/ GM-Tg-hg-IP2623-Ab-2; GM-Tg-rg-IP2623-Ab-1/ GM-Tg-rg-IP2623-Ab-2; GM-Tg-mg-IP2623-Ab-1/ GM-Tg-mg-IP2623-Ab-2; GM-Tg-cynog-IP2623-Ab-1/ GM-Tg-cynog-IP2623-Ab-2; GM-Tg-felg-IP2623-Ab-1/ GM-Tg-felg-IP2623-Ab-2; GM-Tg-cang-IP2623-Ab-1/ GM-Tg-cang-IP2623-Ab-2; GM-Tg-bovg-IP2623-Ab-1/ GM-Tg-bovg-IP2623-Ab-2; GM-Tg-equg-IP2623-Ab-1/ GM-Tg-equg-IP2623-Ab-2 |
Products Name | Anti-NAPG monoclonal antibody |
Format | mab |
Target Name | NAPG |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-NAPG monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2623-Ag-1 | Recombinant multi-species SNAG/ NAPG/ GAMMASNAP protein |
ORF Viral Vector | vGMLP002784 | human NAPG Lentivirus particle |
ORF Viral Vector | pGMLP002784 | human NAPG Lentivirus plasmid |
ORF Viral Vector | pGMLPm001176 | mouse Napg Lentivirus plasmid |
ORF Viral Vector | vGMLPm001176 | mouse Napg Lentivirus particle |
Target information
Target ID | GM-IP2623 |
Target Name | NAPG |
Gene ID | 8774,108123,307382,704546,608647,101099595,509041,100050057 |
Gene Symbol and Synonyms | 2400003O04Rik,GAMMASNAP,NAPG,SNARE |
Uniprot Accession | Q99747,P81127 |
Uniprot Entry Name | SNAG_HUMAN,SNAG_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000134265 |
Target Classification | N/A |
The target: NAPG, gene name: NAPG, also named as GAMMASNAP. This gene encodes soluble NSF attachment protein gamma. The soluble NSF attachment proteins (SNAPs) enable N-ethyl-maleimide-sensitive fusion protein (NSF) to bind to target membranes. NSF and SNAPs appear to be general components of the intracellular membrane fusion apparatus, and their action at specific sites of fusion must be controlled by SNAP receptors particular to the membranes being fused. The product of this gene mediates platelet exocytosis and controls the membrane fusion events of this process.[provided by RefSeq, Dec 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.